Published in Schizophr Bull on January 01, 2002
Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull (2006) 1.75
First aid strategies that are helpful to young people developing a mental disorder: beliefs of health professionals compared to young people and parents. BMC Psychiatry (2008) 1.02
Cultural specificity of emotional overinvolvement: a systematic review. Schizophr Bull (2011) 0.82
Risk and protective factors for relapse among individuals with schizophrenia: a qualitative study in Dar es Salaam, Tanzania. BMC Psychiatry (2014) 0.80
Shame and guilt/self-blame as predictors of expressed emotion in family members of patients with schizophrenia. Psychiatry Res (2012) 0.77
Nonreligious coping and religious coping as predictors of expressed emotion in relatives of patients with schizophrenia. Ment Health Relig Cult (2012) 0.77
Validation of the bipolar disorder etiology scale based on psychological behaviorism theory and factors related to the onset of bipolar disorder. PLoS One (2014) 0.75
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci (2006) 5.15
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry (2009) 2.74
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry (2014) 2.15
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
Musical hallucinations: prevalence in psychotic and nonpsychotic outpatients. J Clin Psychiatry (2004) 1.70
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab (2006) 1.69
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry (2004) 1.55
Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
Effect of implementing dental services in Israeli psychiatric hospitals on the oral and dental health of inpatients. Psychiatr Serv (2009) 1.51
A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
Reboxetine as an optional treatment for hyperkinetic conduct disorder: a prospective open-label trial. J Child Adolesc Psychopharmacol (2005) 1.44
Itching in the psychiatric ward. Acta Derm Venereol (2008) 1.43
Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry (2006) 1.43
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42
Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42
High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome. J Clin Psychopharmacol (2002) 1.40
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry (2013) 1.25
Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study. Am J Psychiatry (2003) 1.24
The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol (2005) 1.24
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr (2002) 1.24
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry (2002) 1.21
Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Am J Med Genet B Neuropsychiatr Genet (2004) 1.20
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry (2007) 1.20
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Effects of climate on admission rates of schizophrenia patients to psychiatric hospitals. Eur Psychiatry (2005) 1.19
Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci (2005) 1.19
Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull (2012) 1.17
Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol (2003) 1.16
Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs (2004) 1.16
Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health. BMC Psychiatry (2011) 1.15
Predictors of schizophrenia--a review. Br Med Bull (2005) 1.15
An integrative quantitative model of factors influencing the course of anorexia nervosa over time. Int J Eat Disord (2009) 1.15
Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol (2012) 1.11
Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry (2013) 1.10
Rituals, stereotypy and compulsive behavior in animals and humans. Neurosci Biobehav Rev (2005) 1.09
Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int J Neuropsychopharmacol (2006) 1.09
Fear thou not: activity of frontal and temporal circuits in moments of real-life courage. Neuron (2010) 1.09
Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol Med (2005) 1.08
Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci U S A (2006) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Isr J Psychiatry Relat Sci (2007) 1.07
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A (2014) 1.07
Prevalence of depression in older people in England and Wales: the MRC CFA Study. Psychol Med (2007) 1.06
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry (2004) 1.06
Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol (2004) 1.05
Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol (2005) 1.05
Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. J Clin Psychiatry (2003) 1.05
The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophr Res (2004) 1.05
Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry (2009) 1.05
Cancer in schizophrenia: is the risk higher or lower? Schizophr Res (2005) 1.05
Heart rate variability in patients with major depression. Psychosomatics (2004) 1.04
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study. Int Clin Psychopharmacol (2006) 1.04
Differences in audiovisual integration, as measured by McGurk phenomenon, among adult and adolescent patients with schizophrenia and age-matched healthy control groups. Compr Psychiatry (2008) 1.02
The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophr Bull (2010) 1.02
Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study. Eur Neuropsychopharmacol (2007) 1.02
Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry (2008) 1.01
Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. Am J Psychiatry (2002) 1.01
The acceptability of routine inquiry about domestic violence towards women: a survey in three healthcare settings. Br J Gen Pract (2006) 1.01
Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS. Int J Neuropsychopharmacol (2007) 1.00
Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J (2008) 1.00